We use our own cookies and those of third parties’ in order to gather web analytics to improve our services. If you continue browsing, we shall assume their acceptance. You can change your browser configuration or read more information.

First NOXtec device in Sri Lanka

By Ingeniería y Técnicas Clínicas

NOXtec is a medical device intended to dose and monitor the supply of inhaled nitric oxide. Specially, they are used to treat pulmonary arterial hypertension. 

Ingeniería y Técnicas Clínicas has designed three version of NOXtec:

- Noxtec 1000: It is a medical device which both dosifies and monitors the supply of nitric oxide. 

- NOXtec 2000: In this version, the dosing flow is set manually and also it monitors the supply of nitric oxide

- NOXtec 3000: This version monitors the supply of nitric oxide. 

ITC had marketed NOXtec in different countries of the world Saudi Arabia, Greece, El Salvador, Guatemala, India, Israel, Malaysia, Turkey or Lebanon. 

This year, the number of countries has been increased due to ITC has installed his first NOXtec 1000 in Sri Lanka

Sri Lanka is an island country located in the south of the Indian Peninsula. Other countries, as Portugal or Holland, had been interested on Sri Lanka because of his strategic position. Sri Lanka is a developing country where the life expectancy is 75 years old and the child mortality rate is 7,45 deaths per every 1.000 live births.

The growing of the life expectancy and the decrease of the child mortality rate show an improvement in health issues even though the adversities in the country as the tsunami in 2004 or civil conflict.

Last January, ITC implemented the first NOXtec device in this country. The equipment was installed in the Castle Street Hospital for Women in Colombo where its first pacient was a young new born. The patient was diagnosed with pulmonary arterial hypertension and her life expectancy was not higher than two weeks.

When the treatment with inhaled nitric oxide started, her health improved significantly and her life expectancy went higher, more than expected by the doctors. 

As we said, the usual treatment of this devices are pulmonary arterial hypertension. Many times, this health issues often are present in neonates, as the patient of Sri Lanka. Thanks to the therapy, her health improved and her life expectancy too. 

We are very glad to help in the improvement of the life expectancy of the people, specially in developing countries where health issues still are growing and getting better.